Socioeconomic Status and Prognosis of Patients With ST-Elevation Myocardial Infarction Managed by the Emergency-Intervention "Codi IAM" Network
Tizón-Marcos, Helena (Institut Hospital del Mar d'Investigacions Mèdiques)
Vaquerizo, Beatriz (Institut Hospital del Mar d'Investigacions Mèdiques)
Ferré, Josepa Mauri (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
Farré, Núria (Institut Hospital del Mar d'Investigacions Mèdiques)
Lidón, Rosa-Maria (Hospital Universitari Vall d'Hebron)
Garcia-Picart, Joan (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya))
Regueiro, Ander (Hospital Clínic i Provincial de Barcelona)
Ariza-Solé, Albert (Hospital Universitari de Bellvitge)
Carrillo, Xavier (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
Duran-Jordà, Xavier (Hospital del Mar d'Investigacions Mèdiques)
Poirier, Paul (Insititut Universitaire de Cardiologie et Pneumologie de Québec)
Cladellas Capdevila, Mercè (Hospital del Mar d'Investigacions Mèdiques)
Camps-Vilaró, Anna (Hospital del Mar d'Investigacions Mèdiques)
Ribas, Núria (Hospital del Mar d'Investigacions Mèdiques)
Cubero-Gallego, Hector (Hospital del Mar d'Investigacions Mèdiques)
Marrugat, Jaume 1954- (Hospital del Mar d'Investigacions Mèdiques)
Universitat Autònoma de Barcelona

Date:	2022
Abstract:	Despite the spread of ST-elevation myocardial infarction (STEMI) emergency intervention networks, inequalities in healthcare access still have a negative impact on cardiovascular prognosis. The Family Income Ratio of Barcelona (FIRB) is a socioeconomic status (SES) indicator that is annually calculated. Our aim was to evaluate whether SES had an effect on mortality and complications in patients managed by the "Codi IAM" network in Barcelona. This is a cohort study with 3,322 consecutive patients with STEMI treated in Barcelona from 2010 to 2016. Collected data include treatment delays, clinical and risk factor characteristics, and SES. The patients were assigned to three SES groups according to FIRB score. A logistic regression analysis was conducted to estimate the adjusted effect of SES on 30-day mortality, 30-day composite cardiovascular end point, and 1-year mortality. The mean age of the patients was 65 ± 13% years, 25% were women, and 21% had diabetes mellitus. Patients with low SES were younger, more often hypertensive, diabetic, dyslipidemic (p < 0. 003), had longer reperfusion delays (p < 0. 03) compared to participants with higher SES. Low SES was not independently associated with 30-day mortality (OR: 0. 95;9 5% CI: 0. 7-1. 3), 30-day cardiovascular composite end point (OR: 1. 03; 95% CI: 0. 84-1. 26), or 1-year all-cause mortality (HR: 1. 09; 95% CI: 0. 76-1. 56). Although the low-SES patients with STEMI in Barcelona city were younger, had worse clinical profiles, and had longer revascularization delays, their 30-day and 1-year outcomes were comparable to those of the higher-SES patients.
Rights:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.
Language:	Anglès
Document:	Article ; recerca ; Versió publicada
Subject:	Inequalities ; Mortality ; Primary percutaneous coronary intervention ; Reperfusion ; ST-elevation myocardial infarction
Published in:	Frontiers in Cardiovascular Medicine, Vol. 9 (april 2022) , ISSN 2297-055X

DOI: 10.3389/fcvm.2022.847982
PMID: 35548422

9 p, 530.4 KB

The record appears in these collections:
Research literature > UAB research groups literature > Research Centres and Groups (research output) > Health sciences and biosciences > Institut d'Investigació en Ciencies de la Salut Germans Trias i Pujol (IGTP)
Articles > Research articles
Articles > Published articles